Deutsche Bank’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.09M | Buy |
32,816
+2,828
| +9% | +$120K | ﹤0.01% | 2135 |
|
|
2025
Q4 | $1.39M | Buy |
29,988
+1,393
| +5% | +$58.3K | ﹤0.01% | 2013 |
|
|
2025
Q3 | $1M | Buy |
28,595
+3,478
| +14% | +$121K | ﹤0.01% | 2166 |
|
|
2025
Q2 | $743K | Sell |
25,117
-39,173
| -61% | -$1.12M | ﹤0.01% | 2268 |
|
|
2025
Q1 | $1.92M | Sell |
64,290
-19,873
| -24% | -$607K | ﹤0.01% | 1781 |
|
|
2024
Q4 | $2.41M | Buy |
84,163
+9,164
| +12% | +$303K | ﹤0.01% | 1714 |
|
|
2024
Q3 | $2.9M | Buy |
74,999
+4,332
| +6% | +$154K | ﹤0.01% | 1544 |
|
|
2024
Q2 | $2.28M | Sell |
70,667
-2,224
| -3% | -$77.1K | ﹤0.01% | 1570 |
|
|
2024
Q1 | $2.83M | Buy |
72,891
+53,644
| +279% | +$1.88M | ﹤0.01% | 1498 |
|
|
2023
Q4 | $592K | Sell |
19,247
-386
| -2% | -$9.67K | ﹤0.01% | 2297 |
|
|
2023
Q3 | $439K | Buy |
19,633
+2,247
| +13% | +$51.2K | ﹤0.01% | 2250 |
|
|
2023
Q2 | $374K | Sell |
17,386
-7,694
| -31% | -$175K | ﹤0.01% | 2522 |
|
|
2023
Q1 | $602K | Buy |
25,080
+8,735
| +53% | +$232K | ﹤0.01% | 2386 |
|
|
2022
Q4 | $379K | Buy |
16,345
+295
| +2% | +$5.95K | ﹤0.01% | 2590 |
|
|
2022
Q3 | $257K | Sell |
16,050
-2,228
| -12% | -$39.3K | ﹤0.01% | 2792 |
|
|
2022
Q2 | $324K | Sell |
18,278
-2,390
| -12% | -$40.2K | ﹤0.01% | 2864 |
|
|
2022
Q1 | $421K | Sell |
20,668
-2,069
| -9% | -$39.1K | ﹤0.01% | 2851 |
|
|
2021
Q4 | $425K | Buy |
22,737
+309
| +1% | +$6.02K | ﹤0.01% | 2938 |
|
|
2021
Q3 | $443K | Sell |
22,428
-215,824
| -91% | -$4.67M | ﹤0.01% | 3122 |
|
|
2021
Q2 | $5.63M | Buy |
238,252
+163,014
| +217% | +$3.77M | ﹤0.01% | 1450 |
|
|
2021
Q1 | $1.78M | Buy |
75,238
+49,474
| +192% | +$1.18M | ﹤0.01% | 2253 |
|
|
2020
Q4 | $516K | Sell |
25,764
-8,295
| -24% | -$162K | ﹤0.01% | 2880 |
|
|
2020
Q3 | $708K | Sell |
34,059
-41,600
| -55% | -$751K | ﹤0.01% | 2424 |
|
|
2020
Q2 | $1.32M | Buy |
75,659
+48,715
| +181% | +$954K | ﹤0.01% | 2048 |
|
|
2020
Q1 | $440K | Sell |
26,944
-105,480
| -80% | -$2.18M | ﹤0.01% | 2546 |
|
|
2019
Q4 | $2.72M | Sell |
132,424
-31,579
| -19% | -$526K | ﹤0.01% | 1783 |
|
|
2019
Q3 | $1.88M | Sell |
164,003
-27,834
| -15% | -$318K | ﹤0.01% | 1956 |
|
|
2019
Q2 | $2.52M | Buy |
191,837
+157,323
| +456% | +$2.1M | ﹤0.01% | 2245 |
|
|
2019
Q1 | $520K | Sell |
34,514
-7,764
| -18% | -$124K | ﹤0.01% | 3423 |
|
|
2018
Q4 | $725K | Sell |
42,278
-35,167
| -45% | -$602K | ﹤0.01% | 3091 |
|
|
2018
Q3 | $1.14M | Sell |
77,445
-104,686
| -57% | -$1.86M | ﹤0.01% | 3228 |
|
|
2018
Q2 | $4.34M | Sell |
182,131
-154,226
| -46% | -$3.79M | ﹤0.01% | 2401 |
|
|
2018
Q1 | $8.59M | Sell |
336,357
-77,758
| -19% | -$1.85M | ﹤0.01% | 1748 |
|
|
2017
Q4 | $7.64M | Buy |
414,115
+348,169
| +528% | +$4.99M | ﹤0.01% | 1694 |
|
|
2017
Q3 | $689K | Buy |
65,946
+1,825
| +3% | +$20.1K | ﹤0.01% | 3233 |
|
|
2017
Q2 | $801K | Buy |
64,121
+32,083
| +100% | +$317K | ﹤0.01% | 3170 |
|
|
2017
Q1 | $320K | Sell |
32,038
-73,624
| -70% | -$1.09M | ﹤0.01% | 3337 |
|
|
2016
Q4 | $1.64M | Sell |
105,662
-17,966
| -15% | -$299K | ﹤0.01% | 2382 |
|
|
2016
Q3 | $2.38M | Buy |
123,628
+55,931
| +83% | +$664K | ﹤0.01% | 2229 |
|
|
2016
Q2 | $801K | Buy |
67,697
+62,273
| +1,148% | +$1.03M | ﹤0.01% | 3035 |
|
|
2016
Q1 | $97K | Buy |
5,424
+1,139
| +27% | +$20.7K | ﹤0.01% | 4030 |
|
|
2015
Q4 | $116K | Sell |
4,285
-15,984
| -79% | -$337K | ﹤0.01% | 3994 |
|
|
2015
Q3 | $447K | Buy |
20,269
+18,666
| +1,164% | +$337K | ﹤0.01% | 3419 |
|
|
2015
Q2 | $28K | Buy |
+1,603
| New | +$27.7K | ﹤0.01% | 4802 |
|
Other funds holding COLL
EAM
VCM
Deutsche Bank's COLL Position: Q1 2026 in Review
Deutsche Bank increased its Collegium Pharmaceutical (COLL) stake by 9.4% in Q1 2026, buying an estimated $120K and bringing the position to 32,816 shares worth $1.09M. The position accounts for ﹤0.01% of the portfolio, ranked #2135.
Deutsche Bank first reported a position in COLL in Q2 2015 and has held it in 44 quarters since. The position peaked at $8.59M in Q1 2018. 266 funds tracked by Wall St. Rank hold COLL as of Q1 2026.
- Deutsche Bank held 32,816 shares of Collegium Pharmaceutical worth $1.09M as of Q1 2026.
- Deutsche Bank bought 2,828 Collegium Pharmaceutical shares in Q1 2026, an estimated $120K.
- Collegium Pharmaceutical made up ﹤0.01% of Deutsche Bank's portfolio in Q1 2026, its #2135 holding.
- Deutsche Bank first reported a position in Collegium Pharmaceutical in Q2 2015 and has held it in 44 quarters since.
- Deutsche Bank's Collegium Pharmaceutical position peaked at $8.59M in Q1 2018.
- 266 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2026.
Based on Deutsche Bank's 13F filing for Q1 2026, filed 6 May 2026.